Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.120
-0.170 (-7.42%)
At close: Apr 21, 2026, 4:00 PM EDT
2.170
+0.050 (2.36%)
After-hours: Apr 21, 2026, 4:00 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $82.98 million as of April 21, 2026. Its market cap has decreased by -29.61% in one year.
Market Cap
82.98M
Enterprise Value
-9.28M
1-Year Change
-29.61%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $82.98M, a decrease of -83.00%. That is a compound annual growth rate of -31.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 89.64M | -21.27% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 109.94M |
| Rapid Micro Biosystems | 102.98M |
| MaxCyte | 91.86M |
| Outset Medical | 84.42M |
| QT Imaging Holdings | 84.30M |
| Xtant Medical Holdings | 70.03M |
| Picard Medical | 67.66M |
| LENSAR | 67.13M |